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Summary
The two-stage process of propensity score analysis (PSA) includes a design stage
where propensity scores are estimated and implemented to approximate a ran-
domized experiment and an analysis stage where treatment effects are estimated
conditional upon the design. This paper considers how uncertainty associated with
the design stage impacts estimation of causal effects in the analysis stage. Such design
uncertainty can derive from the fact that the propensity score itself is an estimated
quantity, but also from other features of the design stage tied to choice of propen-
sity score implementation. This paper offers a procedure for obtaining the posterior
distribution of causal effects after marginalizing over a distribution of design-stage
outputs, lending a degree of formality to Bayesian methods for PSA (BPSA) that
have gained attention in recent literature. Formulation of a probability distribution
for the design-stage output depends on how the propensity score is implemented in
the design stage, and propagation of uncertainty into causal estimates depends on
how the treatment effect is estimated in the analysis stage. We explore these differ-
ences within a sample of commonly-used propensity score implementations (quantile
stratification, nearest-neighbor matching, caliper matching, inverse probability of
treatment weighting, and doubly robust estimation) and investigate in a simulation
study the impact of statistician choice in PS model and implementation on the degree
of between- andwithin-design variability in the estimated treatment effect. Themeth-
ods are then deployed in an investigation of the association between levels of fine
particulate air pollution and elevated exposure to emissions from coal-fired power
plants.
1 INTRODUCTION
Propensity score (PS) analysis refers to a wide range of strategies for estimating causal treatment effects with observational
data. Rubin and others1,2 motivate this process by conceptualizing an observational study as having arisen from a randomized
clinical trial where the rules of assignment have been lost and must be estimated. This perspective draws focus to the “design”
stage of a propensity score analysis (PSA), in which PS are estimated then implemented to create a sub- or pseudo-population
0Abbreviations: PSA, propensity score analysis; BPSA, Bayesian propensity score analysis; NN, nearest neighbor; DEU, design estimation uncertainty; DDU, design
decision uncertainty; AEU, analysis estimation uncertainty
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2 LIAO AND ZIGLER
of the data representative of a hypothesized randomized trial1,3. Following the design stage, observed outcome information is
used to estimate a treatment effect in the “analysis” stage.
A well-conducted design stage is “absolutely essential for drawing objective inferences for causal effects,” and is typically
conducted without access to outcome data1. Many analytic decisions are required to create a successful design which implements
the estimated propensity score (e.g., viamatching, weighting, or subclassification) to achieve treated and untreated groups that are
“balanced” with respect to observed covariates4,5,6,7,8. In traditional PSAs, once the researcher has satisfactorily approximated
the design of the hypothesized randomized study, the sub- or pseudo- population of observations created in the design stage is
treated as fixed or known and estimation of causal effects in the analysis stage is conducted conditional on the design. In light of
the importance of the design stage and the multi-faceted decisions made towards estimating and implementing the propensity
score, it stands to reason that uncertainty associated with the design stage of PSA should be propagated into the estimation of
causal effects in the analysis stage in order to more fully acknowledge all potential sources of PSA uncertainty.
Consideration of design uncertainty is often framed solely in terms of whether and how to incorporate uncertainty from the
estimation of the PS into variance estimation of causal effects9,10,11,12,13,14,15. However, more sources of uncertainty may exist
in the design stage. Dehejia and Wahba16 illustrated that when implementing the PS with nearest neighbor matching without
replacement, the ordering of observations in thematching procedure resulted in different estimates of treatment effect, even when
using the same set of estimated PS16. Abadie and Imbens derive a variance estimator for causal effects that accounts for both
PS estimation uncertainty and uncertainty in the construction of matches17. Further expansion of the idea of design uncertainty
has appeared in Zigler and Dominici, who discuss uncertainty in choice of covariates included in the PS model18, Spertus and
Normand19 who construe probabilistic design weights, and Zigler and Cefalu, who regard the subset of observations pruned (or
truncated) from the design to be unknown6.
Rather than conduct estimation of causal effects conditional on a single design stage, we offer an analysis that first generates a
probability distribution for the space of all possible designs, the structure of which is determined by a) the PS estimation model
and b) the specific type of implementation used in the design. To propagate design uncertainty into effect estimation, inference
in the analysis stage is then marginalized over the distribution of possible designs while maintaining separation between the
outcome data and the design stage. Developing a distribution for the space of designs clarifies the distinction between quantities
we define as 1) “design estimation uncertainty” (DEU) corresponding to familiar notions of estimation uncertainty in the PS, and
2) “design decision uncertainty,” (DDU) corresponding additional stochasticity inherent to some PS implementations which lead
to various design outputs for a fixed value of the PS. Uncertainty arising from treatment effect estimation in the analysis stage is
defined as analysis estimation uncertainty (AEU). These elements of uncertainty are considered in a setting where the following
PSA decisions are made a priori: the causal estimand of interest, the form of the PS model, the type of PS implementation (e.g.,
matching, weighting, etc.), and the method of treatment effect estimation in the analysis stage.
The method described herein is operationalized with the mechanics of Bayesian inference. While performing Bayesian infer-
ence separately in either the “design” or “analysis” stage is straightforward, combining them in a single Bayesian updating
approach requires careful consideration. Bayesian inference that maintains the inherent two-stage nature of PSA gained atten-
tion beginning with McCandless20,21, and continued to appear in following literature22,23,24,25,26. These procedures fall within
a broader class of methods for modularized Bayesian inference27,28, where a “model made of modules" may restrict the prop-
agation of information from one module to another for reasons such as preventing the misspecification of one module from
contaminating another, although there are other motivating considerations28. In the PS context, the design and analysis stages
can be cast as different modules, with care taken so that the analysis does not contaminate the design. Such restricted flow of
Bayesian updating has also been described as a “cut" or a “valve" to prevent feedback of information29,30. One goal of this paper
is to bring together many such issues that have appeared sporadically in literature towards improved understanding of the role
of Bayesian methods for accounting for different elements of uncertainty in a propensity score analysis. As will be elaborated,
deploying the mechanics of Bayesian inference across distinct “design” and “analysis” stages (or modules) has close ties to
multiple imputation (MI) of missing data. As in MI, Bayesian ideas motivate considerations for marginalizing over uncertainty
in the unknown design, but notions of formal Bayesian validity are elusive in this instance, and thus the procedures contained
herein are evaluated on the basis of their “calibration” or Frequentist operating characteristics31,32.
We examine this framework within the context of several commonly-used PS implementations and corresponding analysis
stages: quantile stratification, nearest-neighbor matching with replacement, caliper matching with replacement, inverse proba-
bility of treatment weighting (IPTW), and a common doubly-robust estimator, although the formalization applies to a broader
range of PSAs. We consider both settings where the analysis stage consists of a parametric “outcome model” (conditional on
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the PS), and also settings where no outcome-model likelihood exists, as would be the case with many common non- or semi-
parametric (e.g., matching or weighted) estimators with known asymptotic properties. The latter case is particularly complicated
for Bayesian inference, in which case we propose an approximation to the asymptotic posterior distribution of a causal effect.
The collection of PS analyses considered here is not designed to be exhaustive and we make no argument for superiority of
any given approach. Rather, these specific implementations and analysis stages are used to illustrate the different mechanistic
sources of uncertainty that can arise when performing a PSA.
After distinguishing between different sources of design uncertainty and offering a formalization of integrating design uncer-
tainty into the analysis stage, we outline a corresponding computational algorithm and illustrate the approach in a simulation
study which demonstrates how the quantity of design uncertainty varies under choices a statistician makes in the design stage
- from the variables included in the PS model to the form of PS implementation utilized. Arguments borrowed from MI lit-
erature will be used to compare between- and within-design variability in treatment effect estimates in order to quantify how
design uncertainty impacts posterior inference on treatment effects. We then illustrate this method in an analysis of emissions
from coal-fired power plants and ambient particulate air pollution collected over 22,723 zip codes in the Northeast, Southeast
and Industrial Midwest regions of the United States. The paper concludes with a discussion of possible future directions.
2 NOTATION, ESTIMANDS, AND OVERVIEW OF MARGINALIZING OVER DESIGN
UNCERTAINTY
2.1 Notation and Estimand
Let 푌푖, 푋푖 and 푇푖 represent the observed outcome, covariate vector (of length 푝) and treatment indicator for unit 푖, where 푖 =
1, 2,… , 푛. 푇푖 ∈ [0, 1] is dichotomous and 푌푖 is a continuous random variable. Let 풀 and 푻 be vectorized representations of the
data and 푿 a matrix of observed covariates. We state without comment the following assumptions common to causal inference
literature and defer readers to other work for details1: positivity (each subject has a non-zero probability of receiving either
treatment) and SUTVA (units do not interfere with each other’s outcomes and potential outcomes are well-defined).
The additional key assumption of strongly ignorable treatment assignment states that potential outcomes which exist under
either treatment are independent of observed treatment assignment after adjusting for observed covariates in X, which must
include all confounders. Under ignorability, the average treatment effect (ATE) may be estimated from observed outcomes
among units that exhibit the same distribution in background covariates:
Δ퐴푇퐸 = 퐸[퐸(푌푖|푇푖 = 1, 푋푖) − 퐸(푌푖|푇푖 = 0, 푋푖)] (1)
All relevant covariate information may be summarized in a “coarsened” manner with the propensity score, defined as the
probability to receive the treatment rather than the control conditional on pre-treatment covariates of that individual33. Let 푒푖
represent the propensity score for individual 푖.
푒푖 = 푃 (푇푖 = 1|푋푖) (2)
Units which are homogeneous with respect to 푒푖 are said to be “balanced” with respect to 푋푖, and under the assumption of
strong ignorability, units with the same value of propensity score but assigned to different treatments have an expected difference
in responses equal to the average treatment effect33.
While Δ퐴푇퐸 is defined above as the marginal average treatment effect in the population, Δ (without a subscript) will be used
from this point to generically represent a causal estimand such as the ATE or the ATT(C) (Average Treatment Effect on the
Treated (Control)). The choice of estimand considered is implied by the PS implementation, which is assumed to be chosen a
priori. Differences between estimands are not the focus of this paper, rather, we will consider estimation of each in the context of
a corresponding implementation stage (e.g., matching will be implicitly taken to be estimating the ATT, whereas IPW estimates
the ATE).
2.2 Overview of Marginalizing over Design Uncertainty
We begin with a heuristic description of the proposed framework for Bayesian PSA, deferring details to subsequent sections.
Without the use of the propensity score, traditional Bayesian inference for Δ would follow from specification of a likelihood
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for (푻 ,푿, 풀 ) conditional on unknown parameters, 휃, a prior distribution for 휃, and some function relating the data and 휃 to
the quantity Δ. However, this standard procedure for Bayesian inference to jointly estimate the propensity score and Δ does
not provide reliable causal estimates, as the PS is not intended to be part of the data-generating likelihood for 풀 26,34,35, thus
motivating careful delineation of unknown quantities in the design and analysis stages.
Let 휈 be a parameter summarizing the output of a PS implementation, that is, representing one propensity score “design”
implied by implementing a set of estimated propensity scores. For example, 휈 may be defined as a partition of observations into
strata based on their estimated propensity scores (detailed definition of 휈 is developed in the context of several PS implemen-
tations in Section 3.2). Under the assumptions outlined in Section 2.1 and a design stage that is successful in the sense that it
appropriately balances observed covariates between treated and untreated units, inference forΔmay be carried out with standard
methodology (Bayesian or otherwise) conditional on a single value of 휈, possibly with variance estimators adapted to account
for uncertainty in 휈 36,17,10. Instead of conditioning on a single realization of 휈, the goal of this paper is to marginalize posterior
inference forΔ over the space of reasonable values of 휈, each with an associated probability. This is represented heuristically as:
푓 (Δ|푻 ,푿, 풀 ) = ∫
휈
푓 (Δ|푻 ,푿, 풀 , 휈)푓 (휈|푻 ,푿)푑휈 (3)
The distribution 푓 (휈|푻 ,푿) is written to explicitly acknowledge that the design stage is conducted without outcome infor-
mation (풀 ). Integrating the posterior distribution of Δ over the marginal distribution of 휈 is a mathematical representation of
propagating design uncertainty into the analysis stage by marginalizing over the space of all possible designs.
Expression (3) also highlights an important analog to the analysis of missing data: Construing 휈 as a missing quantity closely
parallels the Bayesian derivation of a multiple imputation procedure, where (푻 ,푿, 풀 ) represent the observed data and the
expression 푓 (휈|푻 ,푿) represents a model for the missing data, intentionally specified in this case to omit 풀 to preclude the
outcome from contributing to the design. Integration over 휈 represents the multiple imputation of “missing” designs, with the
analysis stage conducted conditional on each and, as will be detailed in the subsequent, uncertainty in the parameters governing
the construction of 휈 (in addition to the value of 휈 itself) being propagated into estimates of Δ. The modularity of BPSA means
that, analogous to procedures for multiple imputation, 푓 (Δ|푻 ,푿, 풀 )may not be regarded as a standard Bayesian posterior32,31.
Detailed specification of the modules will follow in Sections 3 and 4, with the corresponding computational procedure described
in Section 4.2.
3 A DISTRIBUTION OF DESIGNS GOVERNING DESIGN UNCERTAINTY
3.1 Bayesian Propensity Score Estimation and Design Estimation Uncertainty
The parameter 휈 represents the result of propensity score estimation and implementation for which ignorable treatment assign-
ment is assumed, thus its probability distribution 푓 (휈|푿,푻 ) must be anchored to the PS estimation model. We expand the
posterior distribution of 휈 to reflect its dependence on parameters from the PS model, which represents the “design module” of
expression (3):
푓 (휈|푿,푻 ) = ∫ 푓 (휈|훼,푿,푻 )푓 (훼|푿,푻 )푑훼 = ∫ 푓 (휈|훼,푿,푻 )퐿(푻 |푿, 훼)휋(훼)푑훼, (4)
where 퐿(푻 |푿, 훼) represents a likelihood function for the treatment assignment mechanism (i.e., a propensity score model) and
휋(훼) represents a prior distribution for the unknown parameter 훼.
For illustration throughout this paper, we consider a simplistic propensity score model based on a generalized linear model
퐿(푻 |푿, 훼) =∏푛푖=1 푔(훼푋푖)푇푖(1− 푔(훼푋푖))1−푇푖 , with a logit link function 푔(훼푋푖), although the ensuing discussion will be relevantto any parametric propensity score model specification with unknown parameter 훼. Note that the propensity score for each
observation, 푒푖, is a deterministic function of (훼,푿,푻 ). In the case of a logistic propensity score model, 푒푖 = 푔(훼푋푖) = 푒휶푋푖1+푒휶푋푖 .A traditional Frequentist estimate of the propensity score may be obtained by replacing the unknown parameter 훼 with its
maximum likelihood estimate. Instead, integrating with respect to 훼 in expression (4) may be thought of as simulating from the
posterior “predictive” distribution of propensity scores for each individual33. From this point forward, we refer to 훼 and the PS
interchangeably with regards to describing a posterior distribution of quantities derived from the treatment assignment model.
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Variability in the predictive distribution of propensity scores captures uncertainty in the estimation of the propensity scores,
which we refer to as “design estimation uncertainty” (DEU). Propagation of DEU into causal effect estimates has been previously
considered in Bayesian and non-Bayesian contexts37,5,23.
3.2 Propensity Score Implementation and Design Decision Uncertainty
Define 휈 as a vector of length 푛, where 휈 = [휈1, 휈2,… , 휈푛] and 휈푖 encodes the output of the PS implementation for individual
푖. The parameter space for each 휈푖 depends upon the choice of PS implementation procedure and the space of the entire vector
휈 may receive additional restrictions based on the details of the implementation. Delineation of the components of 푓 (휈|푻 ,푿)
as expressed in expression (4) draws a distinction between uncertainty derived from estimation of the propensity score (DEU)
and any additional source of uncertainty owing to the stochasticity inherent to the implementation, to which we refer as “design
decision uncertainty” (DDU). The possibility of DDU is denoted by the expression 푓 (휈|훼,푿,푻 ).
A PS implementation may or may not generate DDU. We refer to implementations that do not generate DDU as deterministic
implementations, which produce only one possible value of 휈 for each value of 훼. In these implementations, 푓 (휈|푻 ,푿, 훼) is
a point-mass function and all design uncertainty derives from DEU. In contrast, probabilistic implementations can produce
multiple values of 휈 for a single 훼, as dictated by the non-degenerate distribution 푓 (휈|푻 ,푿, 훼). In the case of probabilistic
implementations, both DDU and DEU contribute to design uncertainty.
We consider specifying 휈 and 푓 (휈|푻 ,푿, 훼) in the context of five propensity score implementations: quintile stratifi-
cation, nearest neighbor matching with replacement, caliper matching with replacement, and weighting for normalized
inverse-probability-weighted (IPW) and doubly-robust (DR) estimators.
3.2.1 Stratification
Stratification is a type of sub-classification performed on quantiles of the estimated propensity score distribution. For this imple-
mentation, 휈푖 may be specified as a categorical variable, with 휈푖 = 푞 if individual 푖 is assigned to strata 푞, when the sample
is stratified into one of 푞 = 1, 2,… , 푄 quantiles. We consider quintile stratification such that 푄 = 5, 휈푖 takes on a value in
[1, 2, 3, 4, 5] and 휈 is defined on the space of possible allocations of 푛 units into quintiles. Stratification is a deterministic PS
implementation method.
3.2.2 Nearest Neighbor Matching With Replacement, implemented with a caliper
Nearest neighbor (NN) matching with replacement considers treated observations one at a time and matches each to the control
observation(s) (ratio of matching decided a priori) with the closest propensity score. Controls are allowed to be matched to
multiple treated observations, and thus may appear multiple times in the matched set. By implementing NN matching with a
caliper, the pool of possible matches is limited by the caliper width, preventing unsuitable matches and instead pruning treated
observations with propensity scores too removed from the distribution of control propensity scores.
In this implementation (and all matching with-replacement implementations), 휈푖 may be defined as the frequency weight for
observation 푖, which is calculated by standardizing the frequency of inclusion of each observation to sum to the number of unique
observations within each treatment arm in the matched set. Thus 휈푖 is defined on the space of real numbers bounded above by
the maximum (across treatments) number of observations within each treatment arm.
As the case with stratification, NN matching with replacement is a deterministic implementation yielding one matched set for
each set of propensity scores and a point-mass function 푓 (휈|푻 ,푿, 훼).
3.2.3 Caliper Matching With Replacement
In addition to NNmatching, we also consider matching with replacement utilizing a caliper, which we refer to as “caliper match-
ing.” While this implementation is not widely used in propensity score literature, we incorporate it specifically as a stochastic
counterpart to the NN algorithm of Section 3.2.2. The difference between the two matching algorithms is that while NN chooses
matches deterministically (closest based on PS distance) caliper matching chooses matches randomly among the candidates
contained within the caliper.
Within the context of caliper matching with replacement, 휈 is defined in the same manner as NN matching with replacement.
However, the random choice of control matches within the caliper renders this a probabilistic implementation; even for a fixed
훼, there may still be variability in 휈 owing to the random selection of matches. 푓 (휈|푻 ,푿, 훼) is a probability distribution without
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an easily obtainable closed-form solution, but draws may be taken via iteratively performing the caliper matching algorithm
multiple times conditional on the same 훼.
3.2.4 Weighting for IPW and DR estimators
In contrast to matching and subclassification, weighting implementations utilize the propensity score to create a “pseudo-
population” of observations in the treatment group, control group, or both in order to balance covariate distributions between the
two groups. Inverse probability weighting (IPW) assigns weights based the following transformation of the propensity score:
푤푖 =
푇푖
푒푖
+
1 − 푇푖
1 − 푒푖
(5)
For IPW, 휈푖 = 푤푖, living on the space of positive real numbers. Since weights are created from a one-to-one transformation
of a given a set of PS, the implementation is deterministic and 푓 (휈|푻 ,푿, 훼) is point-mass. This applies whether the weights are
deployed in a standard IPW analysis or in tandem with an outcome model specification towards construction of a doubly-robust
estimator.
4 SAMPLING FROM THE MARGINAL POSTERIOR DISTRIBUTION OF TREATMENT
EFFECTS
This section puts the distribution of 휈 formulated in Section 3 within the modularized Bayesian framework presented in Section
2.2 with the goal of obtaining posterior inference on the marginalized posterior distribution of treatment effects. Incorporating
the relationship between design output 휈 and the PS model, we expand expression (3) as:
푓 (Δ|푻 ,푿, 풀 ) = ∫
휈
푓 (Δ|푻 ,푿, 풀 , 휈)푓 (휈|푻 ,푿)푑휈 (6)
= ∫
휈
푓 (Δ|푻 ,푿, 풀 , 휈)∫
훼
푓 (휈|훼,푿,푻 )푓 (훼|푿,푻 )푑훼푑휈 (7)
= ∫
휈
푓 (Δ|푻 ,푿, 풀 , 휈)
⏟⏞⏞⏞⏞⏞⏞⏞⏞⏟⏞⏞⏞⏞⏞⏞⏞⏞⏟
AEU
∫
훼
푓 (휈|훼,푿,푻 )
⏟⏞⏞⏞⏞⏞⏟⏞⏞⏞⏞⏞⏟
DDU
휋(훼)
푛∏
푖=1
퐿(푇푖|푋푖, 훼)
⏟⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏟⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏟
DEU
푑훼푑휈 (8)
The posterior distribution of treatment effects conditional on the design is denoted with 푓 (Δ|푻 ,푿, 풀 , 휈), representing the
“analysis module” of BPSA, with variability in this distribution defined as “Analysis Estimation Uncertainty” (AEU). The
functional form of 푓 (Δ|푻 ,푿, 풀 , 휈) is specified a priori, depending in part on the structure of 휈 implied by the design stage.
Some PS implementations permit 푓 (Δ|푻 ,푿, 풀 , 휈) to be specified based on a parametric outcome model, while others dictate
specification of 푓 (Δ|푻 ,푿, 풀 , 휈) using weighted estimators with known asymptotic properties, which are typically not motivated
on Bayesian grounds. Sections 4.1.1 and 4.1.2 outline development in each case.
4.1 Formalizing the conditional posterior distribution of Δ
4.1.1 Analysis stages where Δ is estimated with a parametric model
We first consider settings where the analysis stage consists of estimating a parametric outcome model, conditioned on 휈. Follow-
ing propensity score stratification, for example, the analysis stage may be performed with a parametric outcome model having
the likelihood function 퐿(풀 |푻 ,푿, 풀 , 휈, 휃), where Δ is defined as a function of the data and unknown parameters 휃. Allowing
definition of the conditional posterior distribution of Δ from expression (6) as:
푓 (Δ|푻 ,푿, 풀 , 휈) = ∫ 푓 (Δ|푻 ,푿, 풀 , 휈, 휃)푓 (휃|푻 ,푿, 풀 , 휈)푑휃 (9)
where 푓 (휃|푻 ,푿, 풀 , 휈) = 퐿(풀 |푻 ,푿, 풀 , 휈, 휃)휋(휃) is the posterior distribution of the outcome model parameters under prior
distribution 휋(휃). For illustration, we consider 푓 (⋅) to be a linear regression model with 휃 = (훽, 휎2) representing, respectively,
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a vector of regression coefficients and a conditional variance parameter. In this paper, we only consider a parametric outcome
model in the case of stratification, where 휈, a factor variable indicating stratum membership, is included as a covariate in the
outcomemodel, along with an interaction with the treatment. In this case, the causal effectΔ is a function of 휃 and observed data.
4.1.2 Analysis stages where Δ is estimated with an estimator with known asymptotic properties
Some PS implementations, in particular those based on weighting, do not lend themselves to estimation of Δ with a parametric
outcome model. The form of the estimator depends on the definition of the weights, which we illustrate with implementations
of caliper matching with replacement, NN matching with replacement, IPW, and a simple DR estimator (see Appendix A for
weights and weighted estimators of these implementations). The lack of a parametric model for 풀 and corresponding likelihood
expression requires a different approach for specifying the conditional distribution 푓 (Δ|푻 ,푿, 풀 , 휈) from expression (6).
One option utilized in past literature23 is specification of 푓 (Δ|푻 ,푿, 풀 , 휈) with the known asymptotic distribution of the
estimator for Δ, conditional on one realization of 휈. Let 푄̂(휈) represent an estimator of Δ and 푉̂ (휈) the sampling variance, both
computed conditional on design 휈. Then an asymptotic approximation takes the form:
푓 (Δ|푻 ,푿, 풀 , 휈)∼̇푁(푄̂(휈), 푉̂ (휈)) (10)
Appendix A lists the specific expressions used to approximate 푓 (Δ|푻 ,푿, 풀 , 휈) for BPSA performed with caliper matching,
NN matching, IPW and DR estimation.
When using asymptotic distributions to approximate 푓 (Δ|푻 ,푿, 풀 , 휈), evaluation of the marginal posterior distribution in
expression (6) can be construed as evaluation of the “asymptotic posterior distribution" of Δ, marginalized over design uncer-
tainty. Note that, since the derivation of 푄̂(휈) and 푉̂ (휈) is not typically motivated on Bayesian grounds, they do not easily
incorporate prior information on Δ. Asymptotic estimators with poor finite-sample performance might propagate similar
properties into posterior estimates of Δ.
4.2 Outline of Computational Procedure for Marginalizing over Design Uncertainty
Here we outline a sequential Markov-chain Monte Carlo (MCMC) procedure for evaluating the posterior distribution of causal
effects, marginalized over design uncertainty as defined in expression (10), building off of previous literature23,5,6,19.
4.2.1 Drawing from the posterior predictive distribution of 휈
In the first stage of BPSA, multiple draws are taken from 푓 (휈|푻 ,푿) using the following procedure:
1. Obtain a sample of K draws from the posterior distribution of the parameters of the propensity score model, 훼. This can
be accomplished with standard MCMC routines, for example, with the R package MCMCpack.
2. For each of the K draws from posterior distribution of 훼, calculate propensity scores for each observation with the use
of covariate information 푿. Steps 1 and 2 in combination may be conceived as taking 퐾 samples from the posterior
predictive distribution of propensity scores.
3. For deterministic PS implementations, use the K draws from the posterior predictive distribution of propensity scores to
performK propensity score implementations, each representing a design stage 휈푘, indexed by 푘 = 1, 2, ..., 퐾 . For stochastic
PS implementations, perform the implementation R times conditional on each set of PS for all퐾 draws, resulting in푅×퐾
values of 휈.
The output of the first stage (the design module), which may be performed in its entirety independent of outcome information,
produces either 퐾 or 푅 × 퐾 draws of 휈 from its marginal distribution, 푓 (휈|푇 ,푋), each representing a different design. For the
analysis stage, we simplify notation and use 휈푘 to describe a single simulated output from the design stage, omitting the possible
dependence on 푅 (in the case of probabilistic designs). If the PS distribution is explored well enough (퐾 is large), 푅 does not
need to be too large (and may even be set to 1) as the MCMC algorithm re-visits the same sets of PS multiple times and the
variability of 푓 (휈|푻 ,푿, 훼) is explored in that way.
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4.2.2 Drawing from the conditional posterior distribution of Δ
Estimation in the analysis stage is conducted conditional on each of the simulated values of 휈푘 from the design stage. Specifically,
for each value of 휈푘, 푘 = 1, 2,… , 퐾:
4. Draw 푆 samples from the conditional posterior distribution 푓 (Δ|푻 ,푿, 풀 , 휈푘)
When the analysis stage entails a parametric distribution for 푓 (휃|푻 ,푿, 풀 , 휈푘)
4.1a. Take 푆 draws from the posterior distribution of 휃 = [훽, 휎2], a vector of parameters with the posterior distribu-
tion 푓 (휃|푇 ,푋, 푌 , 휈) ∝ 퐿(푌 |푇 ,푋, 휃, 휈)휋(휃). Let 휃푠푘 represent one such draw, with 푠 = 1...푆. Again, this may be
accomplished with standard MCMC procedure and a packages such as MCMCpack.
4.2a. Each draw of 휃푠푘 may be transformed into Δ푠푘 (ex: for stratification, Δ is a linear combination of coefficients of a
regression fit where treatment assignment is interacted with strata membership).
When an asymptotic approximation is used for the distribution of 푓 (Δ|푻 ,푿, 풀 , 휈푘)
4.1b. Calculate 푄̂(휈푘) and 푉̂ (휈푘).
4.2b. Draw 푆 samples from푁(푄̂(휈푘), 푉̂ (휈푘)) of Δ푠푘, 푠 = 1...푆.
With either step 4a or 4b of the analysis, the end result will be 퐾 × 푆 draws from the posterior distribution 푓 (Δ|푻 ,푿, 풀 ),
which is marginalized over design uncertainty. If interest lies primarily in estimating the posterior mean and variance of Δ,
instead of retaining 푆 draws from 푓 (Δ|푻 ,푿, 풀 , 휈푘) for each 푘, it is only necessary to save Δ푘 = 퐸(Δ|푻 ,푿, 풀 , 휈푘) and 휎2푘 =
푉 푎푟(Δ|푻 ,푿, 풀 , 휈푘), which can be used with Rubin’s combining rules38, to estimate the posterior mean and variance of Δ.
4.3 Between and Within Design Uncertainty
The apparent parallel between the sequential modularized procedure in Section 4.2 and multiple imputation provides a use-
ful analog that relates design uncertainty and analysis uncertainty to notions of “between” and “within” imputation variance.
Construing 휈 as a missing quantity, estimating the mean and variance of Δ with Rubin’s combining rules as 퐸(Δ|푻 ,푿, 풀 ) =
퐸(퐸(Δ|푻 ,푿, 풀 , 휈)) ≈ Δ̄퐾 = ∑퐾푘=1 Δ푘퐾 and:
푉 푎푟(Δ|푻 ,푿, 풀 ) = 퐸(푉 푎푟(Δ|푻 ,푿, 풀 , 휈)) + 푉 푎푟(퐸(Δ|푻 ,푿, 풀 , 휈)) (11)
≈ 휎̄2퐾 +
(
1 + 1
퐾
)
퐵2퐾 =
∑퐾
푘=1 휎
2
푘
퐾
+
(
1 + 1
퐾
)∑퐾푘=1(Δ푘 − Δ̄퐾 )2
퐾 − 1
(12)
Where 퐾 , Δ푘 and 휎2푘 are as defined in Section 4.2.2 and can be calculated whether a parametric distribution or asymptoticapproximation is used in the analysis stage.
The quantity AEU relates to within-design variability (휎̄2퐾 ), quantifying the variability in the distribution ofΔ, conditional on
휈. Design uncertainty (both DDU and DEU) relate to between-design variability (퐵2퐾 ) across the samples from the distributionof 휈. Plummer29 draws parallels between the sequential (or modularized) MCMC procedure of Section 4.2 and concepts in
the MI literature, where the reliability of posterior inference relates to the interplay between these two elements of uncertainty.
Equating 퐾 to the number of “imputed" designs, we define an expression for the proportion of total variability in Δ attributable
to the between-design uncertainty, 푃푅푂푃퐷푈 , which is closely related to the proportion of missing information in a multiple
imputation procedure39:
푃푅푂푃퐷푈 =
퐵2퐾
퐵2퐾 + 휎̄
2
퐾
(13)
In MI, when the percentage of missing information is high, inference on Δ must be treated with caution. The same principle
applies to design uncertainty and the relative influence of between-design variability as quantified in 푃푅푂푃퐷푈 . Section 5
examines the relationship between 푃푅푂푃퐷푈 and BPSA performance in finite samples across several scenarios with varying
amounts of design uncertainty. Examining BPSA through this lens also points towards expected behavior in large samples. As
푛 approaches∞, the posterior distribution of the propensity score model parameters (푓 (훼|퐗,퐓)) will converge to point mass at
the MLE. For implementations with no DDU (i.e., point mass for 푓 (휈|퐗,퐓, 훼)), this would result in between-design variability
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approaching 0 and the within-design variance concentrating around the asymptotic 푉 푎푟(Δ|퐗,퐘,퐓, 휈), which, in combination,
would result in BPSA estimators exhibiting the same asymptotic properties (e.g., coverage) as their Frequentist PSA counterparts.
5 SIMULATION STUDY TO ASSESS DESIGN AND ANALYSIS UNCERTAINTY UNDER
VARYING PS MODELS AND IMPLEMENTATIONS
Here we provide a simulation study to evaluate how different “design choices” made in PSA impact design and analysis uncer-
tainty. Specifically, we implement BPSA to examine design and analysis uncertainty under the different PS implementations
from Section 3.2 and across PS models that include various types of covariates (i.e., confounders, instrumental, prognostic, and
noise variables). To focus on the impact of design choices, the different PS models and implementations will be considered in
Monte Carlo replicates from a single data generating mechanism.
While the primary goal is to examine the different components of uncertainty within BPSA and how quantities such as
푃푅푂푃퐷푈 relate to performance, standard (i.e., Frequentist) PSA estimators will be included for comparison, without claims as
to the superiority of the Bayesian vs. Frequentist approach.
5.1 Data generating mechanism
200 replicated data sets are simulated to have 푛 = 1000 observations and 20 uncorrelated normally-distributed covariates with
mean 0 and variance 1. 5 of these covariates are true confounders associated with both 푇 and 푌 , while 5 are instruments (asso-
ciated with 푇 only), 5 are prognostic (associated with 푌 only) and 5 are noise (associated with neither 푇 nor 푌 ) variables.
Treatment assignment 푇 is simulated from a Bernoulli distribution with probability of treatment specified by the logistic regres-
sion described in Section 3.1, with intercept set to zero and coefficients 훼 set to 0.75 for all confounders and instrumental
variables and 0 for all prognostic and noise variables. Outcomes, 푌 , are simulated from a linear regression model of the form
푌 = 1 + Δ푇 + 훽퐗 + 휖, with Δ set to 1.5, and 훽 set to [0.1, 0.2, 0.3,0.4,0.5] for the five confounders, 0.5 for all prognostic
variables and 0 for noise and instrumental variables. 휖 is a normally-distributed random error with mean 0 and variance 1.
5.2 BPSA and PSA procedures
We analyzed simulated datasets with BPSA (procedure described in Section 4.2 with 퐾 = 1000, 푆 = 200 and 푅 = 1 for
caliper matching) and standard PSA (which conditions analysis on the MLE of the PS) in the context of four different PS model
specifications and six PS implementations.
The four PS model specifications were logistic regressions including the following sets of variables:
1. Only confounders
2. Confounders and instrumental variables
3. Confounders, instrumental and prognostic variables
4. Confounders, instrumental, prognostic and noise variables
Note that all scenarios correctly specify the functional form of the PS model and all include at least the confounders neces-
sary to satisfy the ignorability assumption. When calculating the DR estimator, the potential outcome model utilizes the same
covariates as the PS model.
With each of the two PS model specifications, we employ the following PS implementations: 1-1 caliper matching with a
caliper of 0.5, 1-5 caliper matching with a caliper of 0.5, 1-1 NN matching with a caliper of 0.5, quintile stratification, and
weighting with IPW and DR estimators. Different ratios used for caliper matching were designed to influence the amount of
DDU in the implementation; increasing the number of control matches decreases the amount of DDU.
Under BPSA, the analysis stage following stratification is performed with parametric modeling of the conditional distribution
of Δ (see Section 4.1.1) while the analysis stage following all other implementations involve asymptotic approximation of the
conditional distribution of Δ (see Section 4.1.2).
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FIGURE 1 Relationship between between-design variability and 푃푅푂푃퐷푈 under different PS models and PS implementations
Under PSA, the analysis stage after all implementations utilizes asymptotic estimators for both the treatment effect and
variance, where “robust" variance estimators are employed after caliper matching (with both ratios), NNmatching and IPW esti-
mation and a standard OLS regression is performed for stratification utilizing the same linear model as BPSA (which interacts
treatment and strata membership). The variance estimator for DR under PSA is the conditional variance estimator for Δ which
is utilized in BPSA. Details of all treatment effect and variance estimators may be found on Appendix A.
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FIGURE 2 Relationship between within-design variability and 푃푅푂푃퐷푈 under different PS models and PS implementations
5.3 Simulation Results
A complete table of simulation results, including bias, empirical variance, and mean squared error (MSE) of posterior mean esti-
mates of Δ across replications, average between-design, within-design and total estimated variance across replications, average
푃푅푂푃퐷푈 across replications, and coverage of 95% posterior intervals for the 24 combinations of PS model and implemen-
tation can be found in Table B1. Plots depicting how between design variance (log transformed), within design variance (log
transformed) and bias vary across levels of 푃푅푂푃퐷푈 appear in Figures 1, 2, and 3, respectively.
Compared to a PSmodel that includes only the confounders, adding additional instrumental and prognostic variables increases
average between-design variability for all implementations (Figure 1), with less pronounced impact on within-design variability
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FIGURE 3 Relationship between bias and 푃푅푂푃퐷푈 under different PS models and PS implementations
(Figure 2). As a consequence, adding these variables to the PS model leads to higher average values of 푃푅푂푃퐷푈 within all
implementations.
Under all PS models, the implementations display clear patterns in the amount of 푃푅푂푃퐷푈 they exhibit. DR displays the
lowest 푃푅푂푃퐷푈 under all models, followed by stratification and 1-5 caliper matching. This aligns with the expectation that
these implementations are relatively insensitive to moderate perturbations in the PS. On the other hand, IPW and NN matching
display the highest values in 푃푅푂푃퐷푈 , indicating that even mild perturbations in the PS may result in very different treatment
effect estimates.
Estimates of Δ using IPW display the clearest trend in performance, where high 푃푅푂푃퐷푈 is associated with more erratic
effect estimates in terms of large bias (Figure 3), poor coverage and high variance across replications (Table B1). For IPW, adding
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instrument and prognostic variables has the most impact on the between-design variance of IPW estimates (Figure 1), while
within-design variance is small and largely unaffected by changes to the PS model specification (Figure 2), resulting in large
differences in average 푃푅푂푃퐷푈 across PS models. Performance of Δ estimates is consistent with the expectation that adding
many covariates into the PS model can result causal estimates that are sensitive to extreme weights and low covariate overlap40.
The performance of NN matching, on the other hand, does not suffer as substantially as IPW under PS models which gen-
erate high 푃푅푂푃퐷푈 . Under PS models with instrumental, prognostic and noise variables, NN matching estimates Δ with less
empirical variability across replications than IPW (Table B1) under all PS models since frequency weights are less likely to take
on extreme values compared to IP weights. Coverage levels for NN matching are closer to nominal than IPW under PS models
2-4 due to the comparatively higher average total variance. This is primarily due to NN matching’s between-design variability
(Table B1) which increases as more covariates (regardless of type) are added to the PS model, created by averaging estimates
over designs that consist of different subsets of the data (on average 71% under the confounders-only PS model and on average
63% under other PS models).
Both caliper matching implementations show similar trends to NN matching in terms of the relationship between 푃푅푂푃퐷푈
and Δ’s estimation performance, but with lower average between-design variability, empirical variability, and within-design
variability within each PS model. Comparing NN matching and 1-1 caliper matching, 1-1 caliper matching displays lower
between-design variability because the pool of possible matches displays few changes across draws from the distribution of PS
due to the generous caliper (Section 3.2.3), whereas the “nearest neighbor" of a given observation may change with every PS
draw, resulting in greater differences between designs. 1-5 caliper matching displays less between-design variability than 1-1
caliper matching since the average of 5 matches naturally has less variability across designs than a single match, an example
of decreasing DDU. Among all the matching procedures, 1-5 caliper matching shows the lowest within-design variability (and
tends to include the highest proportion of the observed data - 92% on average - in the design), and 1-1 caliper matching exhibits
slightly lower within-design variability than NN matching. Both caliper matching procedures are similar to NN matching in
their relative insensitivity to 푃푅푂푃퐷푈 in terms of within-design variability. Importantly, the additional DDU associated with
the caliper matching does not translate into increased between-design variability in estimates of Δ, relative to NN matching
(which exhibits no DDU).
Stratification exhibits the lowest average between-design variability among virtually all implementations and across all PS
models, as observations generally remain in the same PS strata across multiple draws from the posterior distribution of the PS
(Table B1). Accordingly, stratification displays low 푃푅푂푃퐷푈 across all PS models, and lower empirical variability estimates of
Δ than the matching or IPW procedures. The stratification approach exhibits slightly more bias than the other procedures, likely
due to the relatively small number of strata.
The DR estimator is unique among our considered implementations as it is the only one which incorporates an explicit
model for potential outcomes that includes direct covariate adjustment. Thus, it is not surprising that its performance deviates
from the general trend of the other implementations. First, within each PS model most replications under DR exhibit much
lower 푃푅푂푃퐷푈 compared to other implementations. While most implementations display only small differences in within-
design variability across PS models, DR displays large increases in average within-design variability in response to adding
instrumental, then prognostic variables to the PS model. For most of the PS models considered, DR displays the largest within-
design variability on average. Between-design variability, however, appears to only moderately increase as instrumental and
prognostic variables are added to the PS model, explaining DR’s relatively smaller 푃푅푂푃퐷푈 under all PS models. The inclusion
of the outcome model in the DR estimate leads to the comparatively low between-design variability, as perturbations in the
propensity score have less impact in effect estimation than the (correctly specified) outcome model.
With the exception of DR, empirical variance of posterior mean estimates of Δ across replications demonstrate a positive
relationship with 푃푅푂푃퐷푈 (Table B1) within each PS model, indicating a correspondence between between-design variability
and variability of point estimates in repeated samples. Designs (combinations of PS models and implementations) which exhibit
high 푃푅푂푃퐷푈 also exhibit more variability in treatment effect estimates across replication and thus require larger estimated
variances in order to achieve nominal coverage.
Results of a standard PSA analysis are presented in Table B2. For the three matching implementations and stratification,
BPSA results in lower empirical variability and MSE due to the averaging over multiple possible matched or stratified designs.
This trend is more evident under PS models which include more than the necessary confounders. In contrast, BPSA versions
of IPW and DR exhibit slightly higher empirical variability and MSE than PSA, with this difference also most pronounced
in the PS models that include prognostic, instrument, and/or noise variables. This may be a consequence of extreme weights,
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where averaging over multiple designs includes those with weights extreme enough to provide erratic estimates and increased
variability.
Standard PSA under the three matching implementations and IPW achieve nearer to nominal coverage than BPSA under
most PS models. For DR, PSA performs similarly to BPSA under all PS models except for the PS model with confounders and
instruments, where BPSA achieves nominal coverage while PSA intervals do not. Finally, with stratification both PSA performs
similarly to BPSA with regard to coverage under all PS models.
6 INVESTIGATING THE EFFECT OF HIGH POWER PLANT EMISSIONS ON AMBIENT
POLLUTION
An ongoing analysis in Cummiskey et. al.41 is evaluating the association between long-term exposure to emissions from coal-
fired power plants and Ischemic Heart Disease (IHD) hospitalizations among Medicare beneficiaries. One important feature of
this analysis is the way in which the analysis incorporates ambient fine particulate matter (particles less than 2.5 micrometers
in diameter, denoted PM). Ambient PM concentrations are expected to be derived in part from coal-fired power plant emissions
in some regions, and PM is known to be associated with a variety of adverse health outcomes42. While the primary analysis in
Cummiskey et. al.41 investigates the link between coal emissions and IHDwithout adjusting for PM, a secondary analysis regards
PM as an adjustment covariate and briefly evaluates whether PM could be ruled out as a possible mediator of the relationship
between coal emissions and IHD hospitalizations. Here we revisit the secondary analysis of Cummiskey et. al.41, deploying the
methods described in Section 5.2 to investigate the extent to which a binary metric of high/low coal emissions exposure causally
impacts annual average PM. Details in Cummiskey et. al.41 describe the creation of a binary metric of coal power plant exposure
derived using a reduced-complexity chemical transport model (InMap)43, as well as the data-fusion derived estimates of PM44.
We examine the effect of elevated coal emissions on ambient particle concentrations measured at 22,723 zip codes in the
Northeast, Southwest and Industrial Midwest regions of the United States. The analysis adjusts for 17 possible confounders,
including location of zip code (latitude and longitude), climate (temperature and humidity), population density, demographics
(e.g. racial makeup, education, household income, gender) as well as the makeup of the residential areas in each zip code (e.g.
urban/rural, real estate value). A full list of covariates considered can be found in Table 1. Further details on consolidating the
zip-code-level covariates (retrieved from 2000 US Census data) may be found in Henneman et. al41.
Among the 22,723 observations in this dataset, 7,211 are classified as “exposed" (to high coal emissions) and 15,512 are
control observations. Figure 4 visualizes the overlap of estimated propensity scores among treated and control observations
using maximum likelihood estimates of the PS, and Table 1 contains average values of included confounders compared across
exposure status. On average, control zip codes are located further West, have lower population densities, are less urban and more
rural, and exhibit a lower median household income and higher percent poverty.
Analysis was performedwith the PSA and BPSA procedures described in Section 5.2, compared within the contexts of quintile
stratification, caliper matching with replacement, NN matching with replacement (both with caliper = 0.5 and a 1-1 ratio), and
weighting with IPW and DR estimators. In this analysis, we focus on estimating the ATE, but employ caliper and NN matching
methods which measure the ATT for purposes of illustration.
Estimated treatment effects, 95% uncertainty intervals and analysis details may be found in Table 2, and are depicted graphi-
cally in Figure 5. Presented on the same scale for comparison are also estimates and intervals constructed via fully adjusted and
unadjusted linear regressions. Between-, within- and total variance for all implementations utilized with BPSA may be found
in Table 3. NN matching, 1-1 caliper matching and IPW all display high 푃푅푂푃퐷푈 at 0.59, 0.49 and 0.46, respectively, while
DR and stratification display relatively lower 푃푅푂푃퐷푈 , at 0.11 and 0.13, respectively (Table 3). This mirrors our simulation
findings, as DR and stratification display less between-design variability compared to the matching and IPW methods.
Both the fully adjusted and unadjusted linear regressions estimate lower treatment effects than any of the propensity score
analysis methods. IPW and stratification produced similar point estimates for the average treatment effect (≈ 1.75) while both
matching implementations display a lower estimation of the ATT. The DR estimator displays the highest ATE estimate, and
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FIGURE 4 Histogram of estimated propensity scores under treated and control observations
its confidence intervals do not overlap with that of any other implementation. The discrepancy between the DR estimate and
the IPW estimate may arise due to the relatively high 푃푅푂푃퐷푈 , to which IPW estimator was shown (in the simulation) to be
sensitive. The discrepancy with the stratification estimator may relate to the relatively small number of strata used.
While point estimates of treatment effects are nearly identical between PSA and BPSA procedures in the context of DR,
IPW and stratification, BPSA point estimates are lower than PSA point estimates in the context of NN matching and caliper
matching. This may be attributed to the large pool of control observations available compared to treated observations. Both
matching algorithms on average use only 50% of the available observations in their treatment effect estimation, and selection of
controls into the matched set is sensitive to design uncertainty arising from both DEU (the PS model includes many possible
confounders, some of which may be instrumental variables) as well as DDU (in the case of caliper matching). By averaging over
multiple matched sets, BPSA was shown to produce more stable estimates of the treatment effect in Section 5 and it is reflected
in this analysis via the contrast between PSA and BPSA-estimated treatment effects.
As witnessed in the simulation study, BPSA produces intervals similar in width to PSA when performed with stratification
and DR. Only under IPW does BPSA create narrower intervals than PSA, a result which occurred in the simulation study when
non-confounders were included in the PS model. The most unexpected result occurs under 1-1 NN and caliper matching, where
BPSA produces slightly wider intervals than PSA, a result not observed in the simulation study. This is due to the difference in
proportion of treated observations, which was on average equal to the proportion of control observations in the simulated data
but much lower than the proportion of control observations in the power plant data. The high number of control observations
creates variability in the treatment effect estimate across draws from the PS distribution, as reflected in the high between-design
variance and 푃푅푂푃퐷푈 displayed by both matching methods (Table 3). The design uncertainty captured by the between-design
variability translates into a higher total variance than PSA.
Overall, the results of the analysis provide the consistent message that elevated exposure to coal-fired power plant emissions
causally increases the overall annual concentration of ambient fine particulate matter, underscoring the care with which the
secondary analysis in Henneman et. al41 should be interpreted.
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FIGURE 5 Estimated ATEs and constructed 95% confidence/credible intervals created via PSA and BPSA
7 DISCUSSION
This paper formalizes a sequential Bayesian procedure for marginalizing causal effect estimates over uncertainty associated with
the design stage of a PSA. The ability to distinctly define design and analysis uncertainty aids understanding of the sensitivity
of causal effect estimate performance to decisions made during the approximation of the design of a randomized study with
propensity scores. The procedure outlined in this paper synthesizes a variety of related ideas that have recently appeared under
the topic of Bayesian methods for propensity score analysis37,5,23,28,29,24.
The simulation study explores how design decisions such as covariate selection for the PS model and choice of PS implemen-
tation dictate not only the quantity of design uncertainty which results, but how it is propagated into estimates of causal effects.
In particular, the simulation showed how a summary measure such as 푃푅푂푃퐷푈 quantifying the relative amount of “between”
and “within” design uncertainty can be useful for understanding the impact of design uncertainty on posterior variability in esti-
mates of Δ. In general, higher 푃푅푂푃퐷푈 was associated with higher variability of Δ point estimates across replications, though
specific impacts of this with regard to coverage and MSE varied between implementations. The primary goal of the simulation
section was not to establish an superiority to BPSA relative to standard PSA. While BPSA resulted in lower MSE for the match-
ing implementations and stratification and comparable coverage to PSA under DR and stratification, neither method appeared
uniformly superior. In order to focus on the nuances around between- and within- design uncertainty, the simulation study con-
sidered the implications of design choices within a single data generation, further limiting our ability to make general claims of
the relative performance of BPSA vs. standard PSA approaches.
The work here shares conceptual similarities to that of Branson45, who compares the analysis stage of a PSA to that of a RCT
with randomization restricted to pre-determined bounds on covariate balance. However, while Branson describes a conditional
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distribution of treatment effects which accounts for certain limitations placed on PS implementations, the paper does not address
uncertainty arising from models or implementations utilized in the design stage nor how to propagate it into estimation of the
treatment effect. Furthermore, Branson primarily focuses on PS matching while this paper extends to any PS implementation.
Our discussion also construes design uncertainty broadly and does not detail all the possible factors of design uncertainty.
However, this subject matter may be related to topics such as low covariate overlap across treatments, low treatment prevalence
and highly correlated confounders. For example, IPW is known to give erratic finite-sample performance in the presence of
low covariate overlap, which we have replicated in our simulations4. Work exploring these connections in further detail would
be a promising extension. Other extensions could incorporate non-parametric, machine-learning46 or flexible18 PS estimation
methods which have become recently popular.
We framed BPSA as a special instance of modularization in Bayesian inference, where the mechanics of posterior updating
were seperated in the “design” module and the “analysis” module. The overlap between posterior inference on modules and
multiple imputation is discussed in Plummer et. al.29, and this paper makes ample use of this connection to frame marginalizing
over design uncertainty through the lens of between- and with- design uncertainty, as would be relevant to an analysis of missing
data. Despite the usefulness of the parallel between BPSA and multiple imputation, better understanding of the limits of this
TABLE 1 Application data: table of unadjusted averages of covariates across treatment
Unexposed Exposed
Number of observations 15,512 7,211
Avg. estimated PS 0.25 0.46
Latitude 38.30 38.37
Longitude -82.84 -79.46
County smoking rate 0.27 0.26
Total population 10,791 13,231
Percent residing in rural area 0.58 0.49
Percent of white residents 0.85 0.82
Percent of African-American residents 0.11 0.13
PctHighSchool 0.35 0.35
Median household income 39,385 43,594
Percent living below poverty threshold 0.13 0.12
Percent female 0.51 0.51
Percent of housing units occupied 0.87 0.90
Percent who have moved in past 5 years 0.42 0.42
Median house value 102,070 121,912
Population per Sq. Mile 1,167 2,455
Avg. temperature (2005) 286 286
Avg. relative humidity (2005) 0.0086 0.0085
TABLE 2 Estimated treatment effects of high power plant emissions on ambient pollution
ATE [95% CI]
UNADJ regression 1.41 [1.35,1.47]
ADJ regression 1.46 [1.41,1.51]
BPSA PSA
NN matching 1.63 [1.52,1.74] 1.65 [1.56,1.74]
Caliper matching 1.59 [1.50,1.68] 1.63 [1.55,1.70]
Stratification 1.75 [1.67,1.84] 1.76 [1.68,1.83]
IPW 1.74 [1.64,1.85] 1.74 [1.65,1.83]
DR 1.95 [1.86,2.05] 1.95 [1.87,2.03]
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commonality could further improve understainding. For instance, 휈 in the present framework is an entirely synthetic parameter
more akin to a latent variable than a missing quantity with a probabilistic missing-data response mechanism, which is key to
establishing both Bayesian and Frequentist validity for estimators based on multiple imputation. Further exploration of the role
that the theory of multiple imputation can play in this context is an interesting direction for future work.
Though propensity score analysis is widely used in various fields including epidemiology and econometrics, notions of design
uncertainty are rarely considered explicitly. Bayesian propensity score analysis provides a versatile computational procedure
which marginalizes over all components of design uncertainty in a clearly defined manner. Though the performance of BPSA
varies across implementations, it has been regarded as an attractive alternative to conditioning inference on a single estimate of
the propensity score5. Explication and exploration of the ideas presented here can hopefully ground future work investigating
how Bayesian methods can add to the existing literature on propensity score analysis.
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APPENDIX
A MODEL SPECIFICATION FOR EXAMINED IMPLEMENTATIONS
A.1 Stratification
Let 휈푖 ∈ [1, ..., 푆] represent the strata which observation 푖 is assigned to. We model the outcome with a linear regression:
퐸(푌푖) = 훽0 + 훽1푇푖 +
푆∑
푠=2
[
훽2푠ퟙ(휈푖=푠) + 훽3푠푇푖ퟙ(휈푖=푠)
] (A1)
Let 푃푠푡 represent the proportion of those in treatment group 푡 who were assigned to stratum 푠, thus 푃푠푡 =
∑푛
푖=1 ퟙ(휈푖=푠)ퟙ(푇푖=푡)∑푛
푖=1 ퟙ(푇푖=푡)
Our
estimate of Δ is then a linear combination of 훽s:
Δ =
∑푛
푖=1 푌푖푇푖∑푛
푖=1 푇푖
−
∑푛
푖=1 푌푖(1 − 푇푖)∑푛
푖=1(1 − 푇푖)
= 훽1 +
푆∑
푠=2
[(
푃푠1 − 푃푠0
)
훽2푠 + 푃푠1훽3푠
] (A2)
Where the effect difference in level 푠 = 1 is represented by 훽1. In Sections 5 and 6, quintile stratification is utilized, setting푆 =
5. When performing standard Frequentist PSA, the MLE estimate for 휷̂ may be substituted for 휷 to calculate Δ. The asymptotic
form for 푉 푎푟(Δ) was derived by Lunceford and Davidian47, which is functionally equivalent to performing a transformation of
the variance-covariance matrix for 휷. We calculated the latter when performing PSA in Section 5.
Since a parametric likelihood may be recovered from this specification of the outcome model, when performing BPSA
퐸(Δ|푻 ,푿, 풀 , 흂) and 푉 푎푟(Δ|푻 ,푿, 풀 , 흂) are simply the conditional posterior mean and variance ofΔ, respectively, as outlined in
Section 4.1.1. In practice, this involves performing a Bayesian linear regression conditional on strata assignments and obtaining
the posterior mean and variance of multiple draws. We utilized a flat prior on 휷.
A.2 DR
Doubly-robust effect estimation is performed as described in Funk et. al.48. Let 푌̂1 represent counterfactual outcomes for an
all-treated sample, estimated with the following model:
퐸(푌푖|푇푖 = 1) = 훽0 + 푝∑
푞=1
훽푞푋푖푞 (A3)
휷̂ is estimated by fitting this regression on the subsample of treated observations, then 푌̂1 is predicted for all observations.
With a similar process, 푌̂0 is also predicted. The following formula is then utilized to estimate 퐸(Δ̂∗(휈)), where 휈푖 is defined in
Equation 5:
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[1
푛
푛∑
푖=1
푇푖푌푖
푒̂푖
−
푌̂1(푇푖 − 푒̂푖)
푒̂푖
]
−
[1
푛
푛∑
푖=1
(1 − 푇푖)푌푖
(1 − 푒̂푖)
−
푌̂0(푇푖 − 푒̂푖)
1 − 푒̂푖
] (A4)
=
[1
푛
푛∑
푖=1
휈푖(푌푖 − 푌̂1) + 푌̂1
]
−
[1
푛
푛∑
푖=1
휈푖(푌푖 − 푌̂0) + 푌̂0
] (A5)
While the following formula from Lunceford and Davidian47 is utilized to estimate 푉 푎푟(Δ̂∗(휈)):
1
푛
[[1
푛
푛∑
푖=1
[푇푖(푌푖 − 휇̂퐼푃푊 ,1)
푒̂푖
−
(1 − 푇푖)(푌푖 − 휇̂퐼푃푊 ,0)
1 − 푒̂푖
]2] − [1
푛
푛∑
푖=1
[√1 − 푒̂푖
푒̂푖
(푌̂1 − 휇̂퐷푅,1) + [
√
푒̂푖
1 − 푒̂푖
(푌̂0 − 휇̂퐷푅,0)
]2]]
(A6)
= 1
푛
[[1
푛
푛∑
푖=1
[
휈푖푇푖(푌푖 − 휇̂퐼푃푊 ,1) − 휈푖(1 − 푇푖)(푌푖 − 휇̂퐼푃푊 ,0)
]2] − [1
푛
푛∑
푖=1
[
(휈푖 − 1)
푇푖−
1
2 (푌̂1 − 휇̂퐷푅,1) + (휈푖 − 1)
1
2−푇푖(푌̂0 − 휇̂퐷푅,0)
]2]]
(A7)
Where 휇̂퐼푃푊 ,1 =
∑푛
푖=1
푇푖푌푖
푒̂푖∑푛
푖=1
푇푖
푒̂푖
=
∑푛
푖=1 휈푖푇푖푌푖∑푛
푖=1 휈푖푇푖
, 휇̂퐼푃푊 ,0 =
∑푛
푖=1
(1−푇푖)푌푖
1−푒̂푖∑푛
푖=1
1−푇푖
1−푒̂푖
=
∑푛
푖=1 휈푖(1−푇푖)푌푖∑푛
푖=1(1−푇푖)휈푖
, 휇̂퐷푅,1 = 1푛
∑푛
푖=1
푇푖푌푖
푒̂푖
− 푌̂1(푇푖−푒̂푖)
푒̂푖
= 1
푛
∑푛
푖=1 휈푖(푌푖 −
푌̂1) + 푌̂1 and 휇̂퐷푅,0 = 1푛
∑푛
푖=1
(1−푇푖)푌푖
(1−푒̂푖)
− 푌̂0(푇푖−푒̂푖)
1−푒̂푖
= 1
푛
∑푛
푖=1 휈푖(푌푖 − 푌̂0) + 푌̂0.
A.3 IPW
When utilizing IPW with BPSA, the conditional distribution of Δ is estimated asymptotically.
The following formula is used to estimate 퐸(Δ̂∗(휈)), where 휈푖 is defined in Equation 5:
Δ =
∑푛
푖=1
푇푖푌푖
푒̂푖∑푛
푖=1
푇푖
푒̂푖
−
∑푛
푖=1
(1−푇푖)푌푖
1−푒̂푖∑푛
푖=1
1−푇푖
1−푒̂푖
(A8)
=
∑푛
푖=1 휈푖푇푖푌푖∑푛
푖=1 휈푖푇푖
−
∑푛
푖=1 휈푖(1 − 푇푖)푌푖∑푛
푖=1(1 − 푇푖)휈푖
(A9)
This is equivalent to the estimation of 훽̂1 in the following regression, when weights are set equal to 휈푖:
퐸(푌푖) = 훽0 + 훽1푇푖 (A10)
For PSA, ̂푉 푎푟(Δ̂) is estimated with the Hubert-White sandwich estimator49, which is known to be conservative. This variance
estimator leads to double-counting of design uncertainty when used to estimate 푉̂ (휈) in BPSA.
We instead estimate 푉 푎푟(Δ∗(휈)) with the following estimator from Lunceford and Davidian47 which assumes the “true"
propensity score (and thus true 휈푖) is known:
1
푛
푛∑
푖=1
휈푖
[
푇푖(푌푖 − 휇퐼푃푊 ,1)2 + (1 − 푇푖)(푌푖 − 휇퐼푃푊 ,0)2
]
(A11)
A.4 NN and caliper matching
When utilizing NN or caliper matching with BPSA, the conditional distribution of Δ is estimated asymptotically.
Both nearest neighbor and caliper matching were performed with the MatchIt package on R. 휈푖, defined as the frequency
weight outputted by the MatchIt object (see Section 3.2.2), is utilized in a weighted regression of the same model as Equation
A10. Estimation of 퐸(Δ̂∗(휈)), 푉 푎푟(Δ̂∗(휈)) (as utilized in BPSA) and ̂푉 푎푟( ̂ )Δ (as utilized in PSA) proceed as described in
Appendix A.3 where frequency weights as described in the MatchIt package documentation50 replace IP weights for 휈.
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TABLE B1 Simulation result table for BPSA
Implementation PS model Empirical var Avg total var Avg between var Avg within var Bias 푃푅푂푃퐷푈 Coverage MSE
Caliper matching (1-1) confound 0.015 0.021 0.005 0.016 0.070 0.241 0.966 0.020
Caliper matching (1-1) instru 0.035 0.027 0.008 0.020 0.091 0.282 0.890 0.043
Caliper matching (1-1) instru_prog 0.023 0.035 0.015 0.019 0.092 0.429 0.964 0.032
Caliper matching (1-1) instru_prog_noise 0.023 0.034 0.015 0.019 0.103 0.420 0.948 0.034
Caliper matching (1-5) confound 0.015 0.017 0.001 0.011 0.070 0.075 0.926 0.020
Caliper matching (1-5) instru 0.035 0.023 0.004 0.013 0.091 0.155 0.862 0.043
Caliper matching (1-5) instru_prog 0.024 0.031 0.011 0.013 0.092 0.353 0.946 0.032
Caliper matching (1-5) instru_prog_noise 0.023 0.030 0.010 0.013 0.103 0.342 0.938 0.033
DR confound 0.014 0.020 0.000 0.019 0.001 0.012 0.960 0.014
DR instru 0.066 0.091 0.009 0.076 0.010 0.082 0.966 0.066
DR instru_prog 0.054 0.134 0.017 0.108 -0.012 0.055 0.998 0.054
DR instru_prog_noise 0.053 0.143 0.016 0.115 -0.003 0.072 1.000 0.053
IPW confound 0.016 0.015 0.004 0.011 0.002 0.252 0.938 0.016
IPW instru 0.068 0.023 0.012 0.011 -0.001 0.438 0.790 0.068
IPW instru_prog 0.079 0.036 0.026 0.011 -0.036 0.646 0.892 0.080
IPW instru_prog_noise 0.084 0.039 0.028 0.011 -0.045 0.668 0.886 0.086
NN matching confound 0.019 0.027 0.009 0.017 0.017 0.349 0.988 0.019
NN matching instru 0.062 0.047 0.024 0.023 0.021 0.473 0.910 0.063
NN matching instru_prog 0.042 0.058 0.036 0.023 0.026 0.573 0.978 0.043
NN matching instru_prog_noise 0.041 0.056 0.033 0.023 0.037 0.567 0.962 0.042
Stratification confound 0.013 0.013 0.001 0.012 0.078 0.042 0.902 0.019
Stratification instru 0.029 0.034 0.005 0.029 0.100 0.133 0.926 0.039
Stratification instru_prog 0.016 0.041 0.012 0.029 0.091 0.290 0.994 0.024
Stratification instru_prog_noise 0.016 0.042 0.012 0.029 0.106 0.285 0.984 0.027
TABLE B2 Simulation result table for PSA
Implementation PS model Empirical var Avg total var Bias Coverage MSE
Caliper matching (1-1) confound 0.021 0.023 0.060 0.930 0.024
Caliper matching (1-1) instru 0.042 0.043 0.084 0.930 0.049
Caliper matching (1-1) instru_prog 0.032 0.041 0.079 0.942 0.038
Caliper matching (1-1) instru_prog_noise 0.030 0.042 0.082 0.946 0.037
Caliper matching (1-5) confound 0.017 0.019 0.061 0.926 0.021
Caliper matching (1-5) instru 0.038 0.039 0.080 0.922 0.044
Caliper matching (1-5) instru_prog 0.027 0.038 0.077 0.940 0.033
Caliper matching (1-5) instru_prog_noise 0.028 0.038 0.085 0.932 0.036
DR confound 0.014 0.018 0.001 0.954 0.014
DR instru 0.053 0.059 0.009 0.924 0.053
DR instru_prog 0.033 0.078 -0.008 0.990 0.033
DR instru_prog_noise 0.033 0.078 -0.001 0.984 0.033
IPW confound 0.016 0.018 0.012 0.954 0.016
IPW instru 0.060 0.052 0.028 0.916 0.061
IPW instru_prog 0.066 0.056 0.009 0.942 0.066
IPW instru_prog_noise 0.069 0.060 0.008 0.938 0.069
NN matching confound 0.025 0.031 0.012 0.964 0.025
NN matching instru 0.088 0.080 0.011 0.928 0.088
NN matching instru_prog 0.065 0.076 0.015 0.960 0.066
NN matching instru_prog_noise 0.074 0.075 0.012 0.934 0.074
Stratification confound 0.013 0.013 0.067 0.906 0.017
Stratification instru 0.034 0.031 0.084 0.912 0.041
Stratification instru_prog 0.021 0.031 0.071 0.980 0.026
Stratification instru_prog_noise 0.021 0.032 0.084 0.962 0.028
